Skip to main content
FinSpry Logo
FinSpry
ABBV logo
ABBV
(NYSE)
AbbVie Inc.
$248.78-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

AbbVie (ABBV) Stock Price & Financial Analysis

AbbVie Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$248.41 - $254.62
52-Week High$267.47
52-Week Low$190.75
Open$251.84
Volume5.13M
Average Volume (3M)4.75M
Market Cap454.19B
Shares Outstanding1.77B
P/E Ratio (TTM)71.98
Forward P/E41.68
Price to Sales (P/S)7.05
Price to Book (P/B)16.52
EV/EBITDA23.86
Revenue (TTM)64.39B
Net Income (TTM)6.31B
Free Cash Flow (TTM)19.98B
EPS (TTM)$3.56
Profit Margin9.80%
Operating Margin28.17%
Return on Equity (ROE)22.95%
Debt to Equity2.65
50-Day MA$254.39
200-Day MA$228.41
52-Week Change18.59%
Annual Dividend$6.83
Dividend Yield2.75%
Payout Ratio191.89%
Last Dividend Ex-DateJul 15, 2026

Frequently Asked Questions About AbbVie

What is the current stock price for ABBV?

As of the latest trading session, ABBV stock trades at $248.78. The 52-week range is $190.75–$267.47, with a day range of $248.41–$254.62.

What is the P/E ratio for ABBV?

AbbVie's trailing P/E ratio is 72.0, meaning investors pay $72.0 for every $1 of annual earnings. The forward P/E is 41.7, reflecting analyst expectations for future earnings. AbbVie operates in the Healthcare sector.

Does ABBV pay dividends?

Yes, AbbVie pays a 2.75% annual dividend yield ($6.83 per share). The payout ratio is 191.9%. The last ex-dividend date was 2026-07-15.

What do analysts recommend for ABBV?

Based on 47 analysts, the consensus for ABBV is Buy.

What is the market cap of ABBV?

AbbVie's market capitalization is $440.59B, classifying it as a mega-cap company. AbbVie operates in the Healthcare sector within the Drug Manufacturers - General industry.